co.don chondrosphere®

DRUG2 trials

Sponsors

co.don AG

Conditions

Articular Cartilage Lesion of the Femoral CondyleCondyle, Trochlea, Tibia or RetropatellarLarge Articular Cartilage Lesions of the Femoral

Phase 2

Assessment of Efficacy and Safety of 3 Different Doses of co.Don Chondrosphere to Treat Large Cartilage Defects

CompletedNCT01225575

co.don AGCondyle, Trochlea, Tibia or Retropatellar, Large Articular Cartilage Lesions of the Femoral

Start: 2010-10-31End: 2018-03-31Updated: 2018-03-19

Phase 3

Efficacy and Safety Study of co.Don Chondrosphere to Treat Cartilage Defects

CompletedNCT01222559

co.don AGArticular Cartilage Lesion of the Femoral Condyle

Start: 2010-10-31End: 2020-02-29Updated: 2021-01-27

Related Papers

Safety and Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroids for Patellofemoral or Tibiofemoral Defects: A 5-Year Follow-up of a Phase 2, Dose-Confirmation Trial

Orthopaedic Journal of Sports Medicine2022-01-0120 citations

A Prospective, Randomized, Open-Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee

Orthopaedic Journal of Sports Medicine2019-07-0181 citations

Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial.

2017-05-1240 citations

The Effect of Cell Dose on the Early Magnetic Resonance Morphological Outcomes of Autologous Cell Implantation for Articular Cartilage Defects in the Knee

The American Journal of Sports Medicine2016-05-2359 citations